Nikolaos E Bechrakis
Overview
Explore the profile of Nikolaos E Bechrakis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
146
Citations
1164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wulff J, Koska B, Giese M, Baumer C, Richter R, Foerster A, et al.
J Appl Clin Med Phys
. 2025 Feb;
:e70009.
PMID: 39962748
Purpose: To investigate the relationship between the stereographic and azimuthal equidistant projection (AEP) of the human retina for radiotherapy planning with OPTOS optomap wide-field fundus images (Optos, UK). Further, the...
2.
Bechrakis N, Joussen A, Heimann H
Klin Monbl Augenheilkd
. 2025 Feb;
242(2):97.
PMID: 39947628
No abstract available.
3.
Jabbarli L, Fiorentzis M, Rating P, Schmidt B, Biewald E, Guberina N, et al.
Radiat Oncol
. 2025 Feb;
20(1):22.
PMID: 39940039
Objective: Preservation of visual acuity remains a challenging issue after globe sparing therapy of large uveal melanoma. The aim of our study was analyzing the functional outcome after brachytherapy with...
4.
Strzalkowski P, Strzalkowska A, Chhablani J, Pfau K, Errera M, Roth M, et al.
Int J Retina Vitreous
. 2024 Sep;
10(1):61.
PMID: 39223678
Background: Large language models (LLMs) such as ChatGPT-4 and Google Gemini show potential for patient health education, but concerns about their accuracy require careful evaluation. This study evaluates the readability...
5.
Anastasova R, Fiorentzis M, Liu H, Dalbah S, Bechrakis N, Seitz B, et al.
Pharmaceuticals (Basel)
. 2024 Jul;
17(7).
PMID: 39065755
Uveal melanoma (UM) represents a rare tumor of the uveal tract and is associated with a poor prognosis due to the high risk of metastasis. Despite advances in the treatment...
6.
Al-Ghazzawi K, Neumann I, Knetsch M, Chen Y, Wilde B, Bechrakis N, et al.
J Clin Med
. 2024 Jul;
13(14).
PMID: 39064038
: To clarify the therapy response in orbital inflammatory diseases (OID), we analyzed the treatment effects of steroid therapy, the use of disease-modifying antirheumatic drugs (DMARDS), and biologicals in our...
7.
Liu H, Tsimpaki T, Anastasova R, Bechrakis N, Fiorentzis M, Berchner-Pfannschmidt U
Cells
. 2024 Jul;
13(14.
PMID: 39056751
Uveal melanoma (UM) is the most common intraocular tumor in adults, and nearly 50% of patients develop metastatic disease with a high mortality rate. Therefore, the development of relevant preclinical...
8.
Lever M, Bogner S, Giousmas M, Mairinger F, Baba H, Richly H, et al.
Pigment Cell Melanoma Res
. 2024 Jul;
37(6):831-838.
PMID: 38994815
Approximately every second patient with uveal melanoma develops distant metastases, with the liver as the predominant target organ. While the median survival after diagnosis of distant metastases is limited to...
9.
Sokolenko E, Fluhs D, Lalos F, Meyer P, Fiorentzis M, Lindziute M, et al.
Can J Ophthalmol
. 2024 May;
59(5):e515-e524.
PMID: 38815956
Objective: To evaluate wolfram as a photon and beta absorber in the management of uveal melanoma with radiotherapy, examining its potential ocular adverse effects and physiologic tolerance using an in...
10.
Jabbarli L, Biewald E, Guberina M, Rating P, Fiorentzis M, Fluhs D, et al.
Eur J Ophthalmol
. 2024 May;
35(1):357-366.
PMID: 38807558
Purpose: Radiation-induced scleral necrosis (RISN) is a less frequent complication of brachytherapy for uveal melanoma, and may require surgical treatment in selected cases. We aimed to identify the prognostic factors...